NewswireToday - /newswire/ -
St Neots, Cambridgeshire, United Kingdom, 2011/12/09 - Vascular scientists at Queen Elizabeth Hospital Birmingham (QEHB) are taking advantage of the flexibility of SonoSite’s M-Turbo® hand-carried ultrasound system to provide a wide range of diagnostic and ultrasound-guided interventional services - SonoSite..
Roger Chan, Vascular Scientist at the QEHB, explained: “Advances in point-of-care ultrasound technology have significantly improved diagnostic confidence for vascular diseases, and hand-carried systems are now routinely used for a variety of vascular applications, including bedside assessments for inpatients on the ward, onestop outpatient clinics, critical care units and in ambulatory theatre. The multi-functional nature of the M-Turbo system is ideally suited to this varied role, offering rapid, good quality imaging for diagnosis and procedure guidance. The portability and robust nature of SonoSite’s systems and probes are also very important, as we need to be able to quickly and easily transport them between clinics, wards and theatres.”
“Our MTurbo systems are increasingly being used to provide specialist services – such as TIA clinics, DVT clinics and prescreening of cardiac cases to assess donor veins – and have also allowed us to introduce ultrasoundguided procedures such as endovenous laser treatment (EVLT) and foam sclerotherapy. The M-Turbo’s compact, ergonomic and user-friendly design also makes it easy to use for all levels of experience levels, from trainees to the most experienced practitioners, and we have been very impressed with both the performance of our instruments and the service we receive from SonoSite; it really does offer the whole package for our needs.”
For more information about SonoSite products, please contact:
SonoSite UK, Alexander House, 40A Wilbury Way, Hitchin SG4 0AP
SonoSite, Inc. (sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.